Figure 2. Evaluation of the prognostic signature in the discovery cohort. (A) Kaplan-Meier plots of overall survival between high- and low-risk patients. (B) Time-dependent receiver operating characteristic (ROC) curve analysis. (C) The risk score distribution. (D) The survival status distribution. (E) Expression heatmap of the four immune-related risk genes.